Results 211 to 220 of about 14,439 (224)
Some of the next articles are maybe not open access.
Clinical and Regulatory Concerns of Biosimilars: A Review of Literature
International Journal of Environmental Research and Public Health, 2020Vesa Halimi +2 more
exaly
Efficacy of Infliximab Biosimilars in Patients With Crohn's Disease
Lancet, The, 2017Giorgio Saracco +2 more
exaly
Knowledge and Use of Biosimilars in Oncology: A Survey by the European Society for Medical Oncology
ESMO Open, 2019Josep Tabernero Caturla +2 more
exaly
Changes in Inflammatory Bowel Disease Patients’ Perspectives on Biosimilars: A Follow-Up Survey
United European Gastroenterology Journal, 2019Silvio Danese, Laurent Peyrin-Biroulet
exaly
Comparing Originator Biologics and Biosimilars: A Review of the Relevant Issues
Clinical Therapeutics, 2017Corrado Blandizzi +2 more
exaly
Biosimilars: What the Oncologist Should Know
Future Oncology, 2019Gary Lyman, Marc Thill, Vladimir Hanes
exaly
The Nocebo Effect: A Clinical Challenge in the Era of Biosimilars
Expert Review of Clinical Immunology, 2018Silvio Danese +2 more
exaly
Biosimilars: How Similar are They?
The International Journal of Artificial Organs, 2005openaire +3 more sources
Biosimilars: A Critical Review of Development, Regulatory Landscape, and Clinical Implications
AAPS PharmSciTechAmanpreet Kaur
exaly

